Cargando…
Any individual with multiple sclerosis who markedly improves neurologically with high-doses of biotin should be evaluated for biotinidase deficiency
Autor principal: | Wolf, Barry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227140/ https://www.ncbi.nlm.nih.gov/pubmed/32440355 http://dx.doi.org/10.1177/2055217320923131 |
Ejemplares similares
-
Outcomes of oral biotin treatment in patients with biotinidase deficiency — Twenty years follow-up
por: Szymańska, Edyta, et al.
Publicado: (2015) -
Severe Distal Motor Involvement in a Non-compliant Adult With Biotinidase Deficiency: The Necessity of Life-Long Biotin Therapy
por: Van Winckel, Géraldine, et al.
Publicado: (2020) -
First microdeletion involving only the biotinidase gene that can cause biotinidase deficiency: A lesson for clinical practice
por: Wolf, Barry
Publicado: (2016) -
Management of anesthesia in biotinidase deficiency
por: Goktas, Ugur, et al.
Publicado: (2014) -
Visual Loss in Biotinidase Deficiency
por: Venugopal, Nataraja P.
Publicado: (2020)